Spotlight on modality & platform development trends

Immuno-Oncology Insights 2023; 4(3), 133–135

DOI: 10.18609/ioi.2023.017

Published: 2 May 2023
Foreword
David Dilillo


“These are truly exciting times in the immuno-oncology research field, as seemingly innumerable novel platforms and modalities emerge and enter the clinic for crucial proof-of-concept studies.”